Literature DB >> 21816905

Suppression of IRF4 by IRF1, 3, and 7 in Noxa expression is a necessary event for IFN-γ-mediated tumor elimination.

Sujan Piya1, Ae Ran Moon, Peter I Song, John Hiscott, Rongtuan Lin, Dai-Wu Seol, Tae-Hyoung Kim.   

Abstract

IFN-γ plays a critical role in tumor immunosurveillance by affecting either immune cells or tumor cells; however, IFN-mediated effects on tumor elimination are largely unknown. In this study, we showed that IFN regulatory factors (IRF) modulated by IFNs up- and downregulated Noxa expression, a prodeath BH3 protein, in various cancer cells. Inhibition of Noxa expression using short hairpin RNA in tumor cells leads to resistance against lipopolysaccharide (LPS)-induced tumor elimination, in which IFN-γ is known as a critical effecter in mice. Chromatin immunoprecipitation analysis in both CT26 cells and SP2/0 cells, sensitive and resistant to LPS-induced tumor elimination, respectively, revealed that the responsiveness of IRF1, 3, 4, and 7 in the Noxa promoter region in response to IFN-γ might be crucial in LPS-induced tumor elimination. IRF1, 3, and 7 were upregulated by IFN-γ and activated Noxa expression, leading to the death of Noxa wild-type baby mouse kidney (BMK) cells but not of Noxa-deficient BMK cells. In contrast, IRF4 acts as a repressor for Noxa expression and inhibits cell death induced by IRF1, 3, or 7. Therefore, although IFN-γ alone are not able to induce cell death in tumor cells in vitro, Noxa induction by IFN-γ, which is regulated by the balance between its activators (IRF1, 3, and 7) and its repressor (IRF4), is crucial to increasing the susceptibility of tumor cells to immune cell-mediated cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21816905     DOI: 10.1158/1541-7786.MCR-11-0185

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  7 in total

1.  Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease.

Authors:  Brent Cameron; Wayne Tse; Raza Lamb; Xiaoxia Li; Bruce T Lamb; Gary E Landreth
Journal:  J Neurosci       Date:  2012-10-24       Impact factor: 6.167

2.  Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer.

Authors:  Gottfried E Konecny; Chen Wang; Habib Hamidi; Boris Winterhoff; Kimberly R Kalli; Judy Dering; Charles Ginther; Hsiao-Wang Chen; Sean Dowdy; William Cliby; Bobbie Gostout; Karl C Podratz; Gary Keeney; He-Jing Wang; Lynn C Hartmann; Dennis J Slamon; Ellen L Goode
Journal:  J Natl Cancer Inst       Date:  2014-09-30       Impact factor: 13.506

Review 3.  Noxa in rheumatic diseases: present understanding and future impact.

Authors:  Karissa E Cottier; Elise M Fogle; David A Fox; Salahuddin Ahmed
Journal:  Rheumatology (Oxford)       Date:  2013-12-17       Impact factor: 7.580

4.  PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4.

Authors:  N Ueno; N Nishimura; S Ueno; S Endo; H Tatetsu; S Hirata; H Hata; M Matsuoka; H Mitsuya; Y Okuno
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

5.  Tumor Suppressor Interferon-Regulatory Factor 1 Counteracts the Germinal Center Reaction Driven by a Cancer-Associated Gammaherpesvirus.

Authors:  Wadzanai P Mboko; Horatiu Olteanu; Avijit Ray; Gang Xin; Eric J Darrah; Suresh N Kumar; Joseph M Kulinski; Weiguo Cui; Bonnie N Dittel; Stephen B Gauld; Vera L Tarakanova
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

6.  UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition.

Authors:  Teresa Ezponda; Daphné Dupéré-Richer; Christine M Will; Eliza C Small; Nobish Varghese; Tej Patel; Behnam Nabet; Relja Popovic; Jon Oyer; Marinka Bulic; Yupeng Zheng; Xiaoxiao Huang; Mrinal Y Shah; Sayantan Maji; Alberto Riva; Manuela Occhionorelli; Giovanni Tonon; Neil Kelleher; Jonathan Keats; Jonathan D Licht
Journal:  Cell Rep       Date:  2017-10-17       Impact factor: 9.423

7.  Role of MXD3 in proliferation of DAOY human medulloblastoma cells.

Authors:  Gustavo A Barisone; Tin Ngo; Martin Tran; Daniel Cortes; Mehdi H Shahi; Tuong-Vi Nguyen; Daniel Perez-Lanza; Wanna Matayasuwan; Elva Díaz
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.